Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting
Bivalent (engine)
Middle income country
DOI:
10.3802/jgo.2024.35.e85
Publication Date:
2024-04-22T06:56:42Z
AUTHORS (5)
ABSTRACT
To compare the health impact and economic benefits among individuals who did not receive human papillomavirus (HPV) vaccine to those received a single dose, or 2 doses. The comparison was stratified by 4 types of in conjunction with primary HPV screening low/middle-income country setting.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....